litlas
ログインアカウント作成

David H. Munn

1987–2025 年に発表

別表記
David, H. Munn
131
論文数
38,022
被引用数
97
h 指数
130
i10 指数

被引用数

David H. Munn の年別被引用数1989 年: 被引用 3 件1990 年: 被引用 5 件1991 年: 被引用 4 件1992 年: 被引用 7 件1993 年: 被引用 2 件1994 年: 被引用 3 件1995 年: 被引用 8 件1996 年: 被引用 13 件1997 年: 被引用 15 件1998 年: 被引用 17 件1999 年: 被引用 31 件2000 年: 被引用 49 件2001 年: 被引用 61 件2002 年: 被引用 122 件2003 年: 被引用 169 件2004 年: 被引用 241 件2005 年: 被引用 323 件2006 年: 被引用 379 件2007 年: 被引用 455 件2008 年: 被引用 415 件2009 年: 被引用 410 件2010 年: 被引用 395 件2011 年: 被引用 383 件2012 年: 被引用 466 件2013 年: 被引用 389 件2014 年: 被引用 489 件2015 年: 被引用 682 件2016 年: 被引用 559 件2017 年: 被引用 715 件2018 年: 被引用 650 件2019 年: 被引用 1,495 件2020 年: 被引用 1,702 件2021 年: 被引用 1,853 件2022 年: 被引用 1,235 件2023 年: 被引用 940 件2024 年: 被引用 1,333 件2025 年: 被引用 688 件2026 年: 被引用 17 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,088 件、この内訳の 27.6%中国: 引用元論文 2,634 件、この内訳の 17.8%ドイツ: 引用元論文 760 件、この内訳の 5.1%イギリス: 引用元論文 692 件、この内訳の 4.7%イタリア: 引用元論文 651 件、この内訳の 4.4%フランス: 引用元論文 505 件、この内訳の 3.4%日本: 引用元論文 477 件、この内訳の 3.2%オーストラリア: 引用元論文 444 件、この内訳の 3%オランダ: 引用元論文 345 件、この内訳の 2.3%カナダ: 引用元論文 337 件、この内訳の 2.3%韓国: 引用元論文 266 件、この内訳の 1.8%スイス: 引用元論文 243 件、この内訳の 1.7%
0%27.6%その他 22.7%

機関

分野

  • Immunology and Microbiology30.4%
  • Medicine30.3%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Neuroscience11.9%
  • Engineering1.8%
  • Agricultural and Biological Sciences0.8%
  • その他2.1%

トピック

  • Immune Cell Function and Interaction7.8%
  • Cancer Immunotherapy and Biomarkers6.2%
  • Immune cells in cancer5.6%
  • Immunotherapy and Immune Responses5.3%
  • Tryptophan and brain disorders5%
  • Gut microbiota and health4.4%
  • その他65.7%

共著者

全論文

検索で開く
  1. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

    著者: Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam, Evan Brady, Ravi N. Padia, Huidong Shi, Muthusamy Thangaraju, Puttur D. Prasad, Santhakumar Manicassamy, David H. Munn, Jeffrey R. Lee, Stefan Offermanns, Vadivel Ganapathy - Immunity 2014 被引用: 2,275

  2. IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

    著者: David H. Munn, Andrew L. Mellor - Trends in Immunology 2016 被引用: 1,024

  3. Ido expression by dendritic cells: tolerance and tryptophan catabolism

    著者: Andrew L. Mellor, David H. Munn - Nature reviews. Immunology 2004 被引用: 2,315

  4. Indoleamine 2,3 dioxygenase and metabolic control of immune responses

    著者: David H. Munn, Andrew L. Mellor - Trends in Immunology 2012 被引用: 1,007

  5. GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase

    著者: David H. Munn, Madhav Sharma, Babak Baban, Heather P. Harding, Yuhong Zhang, David Ron, Andrew L. Mellor - Immunity 2005 被引用: 1,245

  6. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

    著者: Eslam Mohamed, Rosa A. Sierra, Jimena Trillo-Tinoco, Yu Cao, Patrick Innamarato, Kyle K. Payne, Álvaro de Mingo Pulido, Jay K. Mandula, Shuzhong Zhang, Paul Thevenot, Subir Biswas, Sarah K. Abdalla, Tara Lee Costich, Kay Hänggi, Carmen M. Anadon, Elsa R. Flores, Eric B. Haura, Shikhar Mehrotra, Shari Pilon‐Thomas, Brian Ruffell, David H. Munn, Juan R. Cubillos‐Ruiz, José R. Conejo-García, Paulo C. Rodrı́guez - Immunity 2020 被引用: 218

  7. Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism

    著者: David H. Munn, Ebrahim Shafizadeh, John T. Attwood, I. E. Bondarev, Achal Pashine, Andrew L. Mellor - The Journal of Experimental Medicine 1999 被引用: 1,617

  8. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses

    著者: Jay K. Mandula, Shiun Chang, Eslam Mohamed, Rachel Jimenez, Rosa A. Sierra-Mondragon, Darwin Chang, Alyssa Obermayer, Carlos Moran Segura, Satyajit Das, Julio Angel Vázquez-Martínez, Karol Prieto, Ann Chen, Keiran S.M. Smalley, Brian J. Czerniecki, Peter Forsyth, Richard C. Koya, Brian Ruffell, Juan R. Cubillos‐Ruiz, David H. Munn, Timothy I. Shaw, José R. Conejo-García, Paulo C. Rodrı́guez - Cancer Cell 2022 被引用: 155

  9. Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment

    著者: John D. Klement, Priscilla S. Redd, Chunwan Lu, Alyssa D. Merting, Dakota B. Poschel, Dafeng Yang, Natasha M. Savage, Gang Zhou, David H. Munn, Padraic G. Fallon, Kebin Liu - Cancer Cell 2023 被引用: 119

  10. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

    著者: Qing Zhou, Meghan E. Munger, Rachelle G. Veenstra, Brenda J. Weigel, Mitsuomi Hirashima, David H. Munn, William J. Murphy, Miyuki Azuma, Ana C. Anderson, Vijay K. Kuchroo, Bruce R. Blazar - Blood 2011 被引用: 679

  11. Immune suppressive mechanisms in the tumor microenvironment

    著者: David H. Munn, Vincenzo Bronte - Current Opinion in Immunology 2015 被引用: 524

  12. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

    著者: Henrique Lemos, Eslam Mohamed, Lei Huang, Rong Ou, Gabriela Pacholczyk, Ali S. Arbab, David H. Munn, Andrew L. Mellor - Cancer Research 2016 被引用: 325

  13. Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism

    著者: David H. Munn, Min Zhou, John T. Attwood, I. E. Bondarev, Simon J. Conway, Brendan Marshall, Corrie C. Brown, Andrew L. Mellor - Science 1998 被引用: 2,592

  14. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

    著者: Rikke Holmgaard, Dmitriy Zamarin, Yanyun Li, Billel Gasmi, David H. Munn, James P. Allison, Taha Merghoub, Jedd D. Wolchok - Cell Reports 2015 被引用: 488

  15. Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans

    著者: Rahul Shinde, Kebria Hezaveh, Marie Jo Halaby, Andreas Kloetgen, Ankur Chakravarthy, Tiago da Silva Medina, Reema Deol, Kieran Manion, Yuriy Baglaenko, Maria Eldh, Sara Lamorte, Drew Wallace, Sathi Babu Chodisetti, Buvana Ravishankar, Haiyun Liu, Kapil Chaudhary, David H. Munn, Aristotelis Tsirigos, Michael P. Madaio, Susanne Gabrielsson, Zahi Touma, Joan Wither, Daniel D. De Carvalho, Tracy L. McGaha - Nature Immunology 2018 被引用: 201

  16. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

    著者: Rikke Holmgaard, Dmitriy Zamarin, David H. Munn, Jedd D. Wolchok, James P. Allison - The Journal of Experimental Medicine 2013 被引用: 636

  17. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment

    著者: Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M. Teresa Ciudad, Andreas Kloetgen, Bethany MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago da Silva Medina, Stefano Ugel, Aristotelis Tsirigos, Vincenzo Bronte, David H. Munn, Trevor J. Pugh, Daniel D. De Carvalho, Marcus O. Butler, Pamela S. Ohashi, David G. Brooks, Tracy L. McGaha - Science Immunology 2019 被引用: 186

  18. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

    著者: Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra, Carmen M. Anadon, Wenjie Dai, Eslam Mohamed, Ling Cen, Tara Lee Costich, Anthony M. Magliocco, Douglas C. Marchion, Richard Klar, Sven Michel, Frank Jaschinski, Richard R. Reich, Shikhar Mehrotra, Juan R. Cubillos‐Ruiz, David H. Munn, José R. Conejo-García, Paulo C. Rodrı́guez - Nature Communications 2019 被引用: 158

  19. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint

    著者: Miao Yu, Gang Guo, Lei Huang, Libin Deng, Chang-Sheng Chang, Bhagelu R. Achyut, Madison Canning, Ningchun Xu, Ali S. Arbab, Roni J. Bollag, Paulo C. Rodrı́guez, Andrew L. Mellor, Huidong Shi, David H. Munn, Yan Cui - Nature Communications 2020 被引用: 185

  20. Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

    著者: Erik Ladomersky, Lijie Zhai, Kristen L. Lauing, April Bell, Jiahui Xu, Masha Kocherginsky, Bin Zhang, Jennifer D. Wu, Joseph R. Podojil, Leonidas C. Platanias, Aaron Mochizuki, Robert M. Prins, Priya Kumthekar, Jeffrey J. Raizer, Karan Dixit, Rimas V. Lukas, Craig Horbinski, Wei Min, Changyou Zhou, Graham Pawelec, Judith Campisi, Ursula Grohmann, George C. Prendergast, David H. Munn, Derek A. Wainwright - Clinical Cancer Research 2020 被引用: 110

  21. The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation

    著者: Wei Chen, Xueqing Liang, Amanda J. Peterson, David H. Munn, Bruce R. Blazar - The Journal of Immunology 2008 被引用: 454

  22. Indoleamine 2,3-dioxygenase and tumor-induced tolerance

    著者: David H. Munn, Andrew L. Mellor - Journal of Clinical Investigation 2007 被引用: 1,064

  23. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan

    著者: Richard Metz, Sonja Rust, James B. DuHadaway, Mario R. Mautino, David H. Munn, Nicholas N. Vahanian, Charles J. Link, George C. Prendergast - OncoImmunology 2012 被引用: 377

  24. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells

    著者: Mary Ann Zimmerman, Nagendra Singh, Pamela M. Martin, Muthusamy Thangaraju, Vadivel Ganapathy, Jennifer L. Waller, Huidong Shi, Keith D. Robertson, David H. Munn, Kebin Liu - American Journal of Physiology-Gastrointestinal and Liver Physiology 2012 被引用: 277